Brief: Gossamer Bio Inc- U.S. Food And Drug Administration Has Placed A Partial Clinical Hold On All Trials Of GB5121

Gossamer Bio

03/04/2023 21:04

April 3 (Reuters) - Gossamer Bio Inc  GOSS.O :
    * GOSSAMER BIO INC- U.S. FOOD AND DRUG ADMINISTRATION HAS
PLACED A
PARTIAL CLINICAL HOLD ON ALL TRIALS OF GB5121
    * GOSSAMER BIO INC- HAS DECIDED TO TERMINATE ALL ONGOING
STUDIES
AND DISCONTINUE DEVELOPMENT OF GB5121
    * GOSSAMER BIO INC -  FDA'S HOLD ON ALL TRIALS OF GB5121 IN
RESPONSE TO SERIOUS ADVERSE EVENTS THAT HAVE BEEN OBSERVED IN
PHASE 1B/2 STAR-CNS STUDY


Further company coverage:  GOSS.O 

 ((Reuters.Briefs@thomsonreuters.com;))